Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMO contact solution

This article was originally published in The Tan Sheet

Executive Summary

Advanced Medical Optics announces July 23 it will ship a multipurpose solution in early August and expects the product will be widely available by early September. The new product will focus on "comfort and disinfection efficacy incorporating the importance of proper handling and care of contact lenses," the Santa Ana, Calif.-based firm says. The company recently recalled its Complete Moisture Plus after the Centers for Disease Control and Prevention reported a potential link between the product and Acanthamoeba keratitis, a rare eye infection (1"The Tan Sheet" June 4, 2007, In Brief). Separately, the firm says it "continues to believe in the strategic and financial rationale" for acquisition of Bausch & Lomb. AMO says it "reaffirms" its $75 per share offer which is "clearly superior and would deliver more value to B&L shareholders than the current $65 per share merger agreement with Warburg Pincus"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100741

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel